Greg Furrow, M.S., Frqa Email and Phone Number
Greg Furrow, M.S., Frqa work email
- Valid
- Valid
Greg Furrow, M.S., Frqa personal email
- Valid
As a Pharmaceutical and Biologics leader with 20+ years of experience, I enjoy building inspired, motivated and highly effective teams with harmonized best-in-class compliance practices and unified global quality assurance programs. My life-long career passion has been blending my Leadership and Scientific skills with my Regulatory experience for the betterment of Quality Assurance and Compliance in a variety of industries. My abilities to analyze processes and develop actionable cost-savings and process improvements allow me to bring a $MM impact for the overall business.Career highlights:• As Chief Quality Officer and acting CTO/Site Head at Mustang Bio, successfully lead all CMC functions, and served as site head responsible for process development, analytical development, operations, manufacturing, QC testing and QA approval of CAR-T cell therapies. • Led quality, compliance and process improvement initiatives for a global CRO resulting in a 144% increase in EV• Mentored global leaders to achieve continuous improvement in performance metrics• Elected President of the Society of Quality Assurance (SQA) 2014• Represent the US industry in the OECD GLP Discussion Group• Executed global multi-site, best-in-class, computerized system validation (CSV) policies• Trained over 2000 on Regulatory Compliance (cGMP, GLP, GCP)• Revamped the GCP quality system at the Lilly phase 1 clinic in Indianapolis resulting in no findings during the subsequent FDA inspection.• Facilitated dozens of successful FDA inspections in the US and monitoring authority inspections in Europe.• Performed hundreds of internal audits, dozens of international CRO QA inspections including China and Russia, and performed contracted audits/mock FDA inspections of Pharmaceutical companies.• Participate as an instructor for advanced FDA investigator training.Executive Summary:• Documented success creating vision, identifying opportunities, innovating, planning, aligning and executing on technology and business solutions that create performance optimization and impact the bottom line
-
Chief Quality OfficerMustang BioBoston, Ma, Us
-
Chief Quality Officer And Site HeadMustang Bio Apr 2024 - PresentWorcester, Massachusetts, Us
-
Chief Quality Officer And Interim Site HeadMustang Bio Aug 2023 - Apr 2024Worcester, Massachusetts, Us
-
Interim Cto And Senior Vice President Of QualityMustang Bio Jan 2023 - Aug 2023Worcester, Massachusetts, UsResponsible for Manufacturing Science and Technology, Preclinical Sciences (Process Development, Analytical Development and Translational Science), CMC Development, Quality Assurance, Quality Control Laboratories, Operations and Facilities.
-
Senior Vice President Of QualityMustang Bio Apr 2022 - Jan 2023Worcester, Massachusetts, Us
-
Vice President Of QualityMustang Bio Jan 2019 - Apr 2022Worcester, Massachusetts, UsDirectly responsible for leading the Quality Organization inclusive of Clinical Quality Assurance, Manufacturing Quality Assurance, Quality Control Chemistry, Microbiology, and Raw Material, and Quality Systems in compliance with Food and Drug Administration (FDA) current Good Manufacturing Practices (cGMP), Good Clinical Practices (GCP), Good Laboratory Practices (GLP), and current ICH requirements. Work across the Mustang organization to build and maintain a world-class organization and establish and maintain a robust and efficient Quality System. Manage the Mustang Bio. Inc. relationship with FDA and other US and global monitoring authorities to assure facilities, policies and procedures are compliant and inspection ready.Mustang Bio, Inc., A Fortress Biotech company, is a biopharmaceutical company focused on the development of novel immunotherapies based on ground breaking chimeric antigen receptor (CAR) research and gene therapies in areas of unmet needs.
-
Vice President, Quality And ComplianceSouthern Research Sep 2016 - Dec 2018Birmingham, Alabama, UsKey Focus:• Lead Quality and Compliance, Bio Safety, ISO 9000, Human Resources, IT, EH&S, and Export Control for this 501(c)(3) nonprofit, scientific research organization with ~500 scientists and engineers working with the following: o Pharmaceutical, Biotechnology, Defense, Aerospace, Environmental and Energy industries: National Cancer Institute, National Institutes of Health, U.S. Department of Defense, U.S. Department of Energy, NASA, Aerospace, Utilities, and other private and government organizations• Serve as the Institutional Official for Biosafety and IACUC• Focus on accelerating data quality improvement, enhancing good documentation practices procedures and training, as well as implementing enhanced safety procedures• Perform compliance, consulting, training and audits for clientsKey Results:• Developed and executed key metrics to monitor and improve quality and compliance (IT, HR, Bio Safety, EH&S)• Implemented and completed an enterprise-wide voice of the employee survey• Launched Six Sigma program: first round of green belt teams targeted improvements in efficiency, cycle time, and $400k+ in savings -
Limited Term InstructorPurdue University Jan 2017 - May 2017West Lafayette, In, Us -
ExecutiveFurrow Apr 2016 - Sep 2016Experienced executive with proven skills in FDA, OECD and EPA regulatory compliance, environmental health and safety compliance, executive management, quality improvement, personnel development and coaching, metric development, team building, and strategic planning.
-
Vice President, Quality And Regulatory ComplianceWil Research Jun 2011 - Apr 2016Key Focus:• Recruited by CEO to unify a decentralized quality organization and to enhance and harmonize compliance procedures globally for this large company employing 1400 scientists, technicians and support staff across US / Europe ($220M annual revenue)• Provided Quality and Compliance oversight for product safety, toxicological research, bioanalytical, regulatory compliance, formulation and manufacturing services for pharmaceutical, biotechnology, industrial and agricultural chemical industries (GLP, cGMP)Key Results:• As member of Executive team, drove revenue CAGR of 11% and adjusted EBITDA CAGR of 13%, which led to a successful exit strategy in early 2016 to Charles River for $585M (12.9x TTM EBITDA) • As member of Executive team, increased enterprise value by 144% generating a 50% IRR for investors• Performed QA and EH&S due diligence of Ricerca Biosciences’ Lyon, France business resulting in acquisition by WIL; the Lyon site = 16x ROI within three years• Created globally integrated QA functional unit from complex, fragmented decentralized local QA groups • Created QA and EH&S metrics presented monthly to key company leaders resulting in continuous improvement in quality, compliance and safety• Managed the WIL relationship with global monitoring authorities; assured compliance policies at all facilities were compliant with current requirements• Performed targeted regulatory training and compliance consulting for multiple sponsor companies on request -
PresidentSociety Of Quality Assurance Jan 2014 - Dec 2014Charlottesville, Virginia, Us -
Sr Director, Regulatory Affairs And ComplianceCharles River Jun 2006 - Jun 2011Wilmington, Massachusetts, UsKey Focus:• Directed Regulatory Affairs and Compliance for company providing essential products and services to accelerate client research and drug development efforts, including: o Global Pharmaceutical, biotechnology, government agencies, and leading academic institutions• Served as GLP QA Lead for a major sponsor’s internal GLP improvement effort• Led QA oversight of construction, validation and creation of compliance oversight program for Charles River’s Shrewsbury site and led GLP QA functional groups at Wilmington, Worcester, Shrewsbury and all Pathology Associates locationsKey Results:• Led successful on-time validation and start-up of Charles River’s best-in-class facility in Shrewsbury MA.• Decommissioned the Charles River Worcester MA site• Executed improved data quality procedures / training =10x decrease in data quality issues• Served on the editorial board for the DIA publication: Computerized Data Systems for Nonclinical Safety Assessment: Current Concepts and Quality Assurance o As a result, executed improved computerized system validation procedures• Reduced client audit response time to less than 10 business days• Trained operations management to perform weekly focused internal assessments o Client audit observations reduced to < 20% of audits resulting in findings reports -
Manager, Quality Assurance. Toxicology, Drug Disposition, Elanco And Discovery ResearchEli Lilly And Company Jul 1985 - Jun 2006Indianapolis, Indiana, UsKey Focus:• Managed Research Quality Assurance oversight (GLP, GCP)• Other roles included: Human Resources Account Manager, Department Head for Quality Control and Analytical Services (cGMP), Productivity Projects Facilitator, Analytical ChemistKey Results:• Integrated Elanco Animal Health and Lilly Pharmaceutical QA units (synergy/reduced QA headcount)• Led quality improvement effort and revamped the quality systems at the Lilly Phase I clinic which culminated in an FDA inspection with no 483 issued; (no adverse findings)• Co-created good research practices policies for Discovery Research / QA oversight• Created QA training for QC groups which resulted in improved quality (less than 3 QA findings per report) and enabled QA to maintain productivity with reduced headcount -
ChemistUsda 1982 - 1985Washington, Dc, UsKey Skills and Expertise:#LeanSixSigma#ProcessImprovement#ProgramManagement#ProjectManagment#QualityAssurance#RegulatoryCompliance#TQM#ConsultantGLPGCPcGMPComputerized System ValidationSix SigmaQuality ImprovementMentoringPersonnel developmentCoachingLeadershipExecutive managementDrug DevelopmentQuality ConsultingRegulatory trainingGlobal RegulationsOECD GLP discussion groupSociety of Quality AssuranceHonorary Life Fellow of the Research Quality AssociationQuality Control LaboratoryInstitutional OfficialGLP NPRMSQA distinguished SpeakerAnimal Health OLAW / USDAFDA / EPA / AuditsPharmaceuticalsEH&S / Bio SafetyIT / Systems / SoftwareSafety ProtocolsCyber / Data SecurityGlobal Liaison Merger / AcquisitionResearch / DevelopmentPolicies / ProceduresTraining DevelopmentHiring / RetentionCoaching / Mentoring
Greg Furrow, M.S., Frqa Skills
Greg Furrow, M.S., Frqa Education Details
-
University Of MarylandAnalytical Chemistry -
High Point High School
-
Innovation University
Frequently Asked Questions about Greg Furrow, M.S., Frqa
What company does Greg Furrow, M.S., Frqa work for?
Greg Furrow, M.S., Frqa works for Mustang Bio
What is Greg Furrow, M.S., Frqa's role at the current company?
Greg Furrow, M.S., Frqa's current role is Chief Quality Officer.
What is Greg Furrow, M.S., Frqa's email address?
Greg Furrow, M.S., Frqa's email address is gr****@****ail.com
What schools did Greg Furrow, M.S., Frqa attend?
Greg Furrow, M.S., Frqa attended University Of Maryland, High Point High School, Innovation University.
What skills is Greg Furrow, M.S., Frqa known for?
Greg Furrow, M.S., Frqa has skills like Quality System, Toxicology, Glp, Computer System Validation, Validation, Fda, Sop, Cro, Leadership, Program Management, Auditing, Regulatory Affairs.
Who are Greg Furrow, M.S., Frqa's colleagues?
Greg Furrow, M.S., Frqa's colleagues are Marinel Lamaj, Robert Marino, Faith Conroy, Evan Selwyn, Niharika Asthana, Kahraman Tekin, Mehdi Amiri.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial